NCT00286871View on ClinicalTrials.gov

Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

February 28, 2009

Conditions
Chronic Hepatitis COrgan TransplantationImmunosuppression
Interventions
DRUG

Neoral

DRUG

Tacrolimus

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Duke University

OTHER